The acquisition pairs Oobli's industry-leading protein production platform and sweet protein portfolio with Amyris' market-proven strain engineering and biomanufacturing capabilities.

此次收购将 Oobli 行业领先的蛋白质生产平台和甜味蛋白产品组合，与 Amyris 经市场验证的菌株工程及生物制造能力相结合。

EMERYVILLE, Calif.

加利福尼亚州埃默里维尔

,

，

Nov. 12, 2026

2026年11月12日

/PRNewswire/ -- Today, Amyris, Inc., a vertically integrated biomanufacturing company, announced that it will acquire Oobli, the leading sweet protein innovator whose fermentation-based sweet protein ingredients help food and beverage brands reduce sugar without sacrificing taste.

/美通社/ -- 今日，垂直整合生物制造公司Amyris, Inc.宣布将收购Oobli。Oobli是领先的甜味蛋白创新企业，其基于发酵工艺的甜味蛋白成分帮助食品和饮料品牌在不牺牲口感的前提下减少糖分。

The acquisition brings together Amyris' broad scientific capabilities and manufacturing depth with Oobli's protein fermentation expertise. Following Amyris' manufacturing capacity expansion earlier this year at its advanced fermentation facility in Barra Bonita, Brazil, this acquisition marks a strategic commercial and technology expansion, accelerating Amyris' footprint in the protein- and peptide-based solution space across end-markets..

此次收购将Amyris广泛的科学能力和深厚的制造实力与Oobli在蛋白质发酵方面的专业知识相结合。继今年早些时候Amyris位于巴西巴拉博尼塔的高级发酵工厂扩大产能之后，此次收购标志着其在商业和技术领域的战略扩张，加速了Amyris在面向终端市场的蛋白质和肽基解决方案领域的布局。

'In Oobli, we see a commercial and technology platform that is a great complement to our own,' said Amyris Chief Executive Officer, Kathy Fortmann. 'Oobli is poised to transform how sweetness makes it to market, and we are thrilled to bring our commercial scale and resources to further accelerate the sweet revolution.

“在Oobli身上，我们看到了一个与我们自身平台形成绝佳互补的商业和技术平台。”Amyris首席执行官Kathy Fortmann表示。“Oobli有望彻底改变甜味产品进入市场的方式，我们非常高兴能够贡献我们的商业化规模和资源，以进一步加速这场甜味革命。”

Further, by bringing Oobli's protein expertise together with our strain engineering, manufacturing scale, and commercial capabilities, we see the potential to broaden our capabilities in food and beverage, personal care, flavor and fragrances, agriculture, and beyond, expanding the ways we can help customers innovate.'.

此外，通过将Oobli在蛋白质领域的专业知识与我们的菌株工程、规模化生产能力和商业能力相结合，我们看到在食品和饮料、个人护理、香料和香精、农业等领域拓展能力的潜力，从而扩大我们帮助客户创新的方式。

Oobli's commercial portfolio of sweet proteins will be the first to benefit from the combined platform. Oobli has spent the past decade refining a fermentation process to produce sweet proteins naturally found in rare fruits and berries near the equator. Oobli's sweet proteins are the first of their kind in the sugar reduction category.

Oobli 的甜味蛋白商业产品组合将率先从这一综合平台中受益。在过去十年中，Oobli 不断完善发酵工艺，以生产天然存在于赤道附近稀有水果和浆果中的甜味蛋白。Oobli 的甜味蛋白是减糖领域中的首创产品。

Sweet proteins are hundreds to thousands of times sweeter than sugar, bind directly to sweet taste receptors, and are metabolized by the body as protein, delivering sweetness without gut disruption or blood sugar spikes..

甜味蛋白的甜度是糖的数百至数千倍，可直接与甜味受体结合，并作为蛋白质被人体代谢，在提供甜味的同时，不会扰乱肠道功能或引起血糖骤升。

Oobli's portfolio, which includes Oubli Fruit, Serendipity Berry and Katemfe Fruit Sweet Proteins (scientifically known as brazzein, monellin, and thaumatin, respectively), has FDA GRAS status as an ingredient and is FEMA GRAS-affirmed for use as a natural flavor. With growing consumer awareness of metabolic health and the benefits of sugar reduction, sweet proteins give brands a new tool to reduce sugar across a broad range of categories, from sports & nutrition and dairy to beverages, chocolate, bakery, and confectionery..

Oobli的产品组合包括Oubli水果、Serendipity浆果和Katemfe水果甜蛋白（科学上分别称为brazzein、monellin和thaumatin），其作为成分已获得美国食品药品监督管理局（FDA）的“一般认为安全”（GRAS）地位，并被香料和萃取物制造商协会（FEMA）确认为可用作天然香料的GRAS物质。随着消费者对代谢健康及减糖益处的认知不断提升，甜蛋白为品牌提供了一种新工具，可在从运动营养和乳制品到饮料、巧克力、烘焙食品和糖果等众多品类中实现减糖。

'At Oobli, we have always believed there was a better way to deliver the sweet taste consumers love, without the trade-offs to health and our environment. It is with immense pride that we look back on the breakthroughs we have achieved,' said Oobli Chief Executive Officer Ali Wing. 'Joining forces with Amyris gives us the scale and resources to realize our ambition of making sweet proteins the global standard in sweetness solutions.

“在Oobli，我们始终相信，有一种更好的方式能够呈现消费者喜爱的甜味，同时无需以牺牲健康和环境为代价。回顾我们所取得的突破，我们深感自豪。”Oobli首席执行官Ali Wing表示，“与Amyris携手合作，使我们具备了实现雄心壮志所需的规模和资源，让甜味蛋白成为全球甜味解决方案的标准。”

Sweet proteins are an idea whose time is now.'.

“甜味蛋白正是当下应时之念。”

Fortmann added, 'At Amyris, we've seen that biomanufactured solutions win when they align with consumer demand and market needs. Oobli's sweet protein platform does exactly that – giving brands a new way to deliver on sweet taste, sugar reduction, and clean label all at the same time. We could not be more excited to welcome the Oobli team into the Amyris family and collectively realize the synergies between our two innovative platforms.'.

Fortmann 补充道：“在 Amyris，我们发现，当生物制造解决方案与消费者需求和市场需求相契合时，便能脱颖而出。Oobli 的甜味蛋白平台正是如此——它为品牌提供了一种全新方式，能够同时实现甜美口感、减糖和清洁标签。我们对欢迎 Oobli 团队加入 Amyris 大家庭感到无比兴奋，并期待共同实现我们两大创新平台之间的协同效应。”

The acquisition is expected to close in the coming weeks. As the breakthrough portfolio of Oobli sweet proteins continues to expand as part of the Amyris family, all existing customer commitments and brand partnerships will continue to be honored uninterrupted.

该收购预计将在未来几周内完成。随着Oobli甜味蛋白作为Amyris家族一部分的突破性产品组合持续扩展，所有现有的客户承诺和品牌合作伙伴关系将继续得到 uninterrupted 的履行。

About Amyris

关于 Amyris

Amyris is a vertically integrated biomanufacturing company that creates specialty molecules for a range of industries, including flavors and fragrances, advanced materials, beauty and personal care, food, and more. Using advanced fermentation technology, Amyris customizes, creates, and manufactures ingredients that enhance lives, protect ecosystems, and take products to the next level of performance..

Amyris 是一家垂直整合的生物制造公司，为包括香料与香精、先进材料、美容与个人护理、食品等在内的多个行业创造特种分子。凭借先进的发酵技术，Amyris 定制、开发并生产能够提升生活品质、保护生态系统并将产品性能推向新高度的原料。

Amyris was founded in 2003 with a bold humanitarian vision to transform access to a life-saving antimalarial compound using biotechnology. Now, with over two decades of proven commercial success, our proprietary platform is redefining the precision, consistency, and sustainability that is possible with renewable biological chemistry..

Amyris 成立于 2003 年，秉持着一项大胆的人道主义愿景，即利用生物技术改变人们对一种挽救生命的抗疟疾化合物的获取方式。如今，凭借二十多年经证实的商业成功，我们的专有平台正在重新定义可再生生物化学在精确性、一致性和可持续性方面所能达到的高度。

About Oobli

关于 Oobli

Oobli is transforming the future of sweet through non-GMO sweet proteins that help food and beverage companies significantly reduce sugar without sacrificing taste. Originally found in fruits and berries near the equator, sweet proteins taste like sugar but digest as protein. Oobli's sweet protein portfolio has FDA GRAS-status as an ingredient and FEMA GRAS-affirmed for use as a natural flavor.

Oobli 正在通过非转基因甜味蛋白重塑甜味的未来，帮助食品和饮料公司在不牺牲口感的前提下大幅减少糖分。这些甜味蛋白最初发现于赤道附近的水果和浆果中，味道像糖，但以蛋白质方式消化。Oobli 的甜味蛋白产品组合已作为成分获得美国食品药品监督管理局（FDA）的“一般认为安全”（GRAS）地位，并获美国香料和萃取物制造者协会（FEMA）确认可作为天然香料使用。

Oobli currently offers the Oubli Fruit Sweet Protein, Serendipity Berry Sweet Protein, and Katemfe Fruit Sweet Protein. Through its Oobli Inside™ platform, consumers can enjoy protein-sweetened, delicious foods and beverages with dramatically less sugar and sugar alternatives and less impact on the environment..

Oobli 目前提供 Oubli 水果甜味蛋白、Serendipity 莓果甜味蛋白和 Katemfe 水果甜味蛋白。通过其 Oobli Inside™ 平台，消费者可以享受由蛋白质提供甜味的可口食品和饮料，这些产品大幅减少了糖及代糖的使用，并对环境的影响更小。

SOURCE Amyris, Inc.

来源：Amyris, Inc.